January 24, 2009Open Access

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Key Points

Key points are not available for this paper at this time.

Abstract

Adjuvant radiotherapy after radical prostatectomy for a man with pT3N0M0 prostate cancer significantly reduces the risk of metastasis and increases survival.

Read Full Paperexternally

AIに質問

Bookmark

View Full Paper

Cite This Study

Thompson et al. (Sat,) studied this question.

synapsesocial.com/papers/6a05138f6c3d07813971bc14 https://doi.org/https://doi.org/10.1016/j.juro.2008.11.032

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors2008 · 2,262 citations
2Cancer Statistics, 20082008 · 10,201 citations
3Symptoms Suggestive of Chronic Pelvic Pain Syndrome in an Urban Population: Prevalence and Associations With Lower Urinary Tract Symptoms and Erectile Function2007 · 65 citations
4Radiation therapy after radical prostatectomy: why patience is a virtue! The case for salvage radiation therapy.2002 · 10 citations
5Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes2007 · 841 citations

AIに質問

Bookmark

View Full Paper